We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Oncology

Journal Scan / Research · August 14, 2020

Updated Overall and Progression-Free Survival Data for Patients With Treatment-Naïve Advanced ALK+ NSCLC

Annals of Oncology

 

Additional Info

Annals of Oncology
Updated Overall Survival and Final Progression-Free Survival Data for Patients With Treatment-Naive Advanced ALK-Positive Non-Small-Cell Lung Cancer in the ALEX Study
Ann. Oncol 2020 Aug 01;31(8)1056-1064, T Mok, DR Camidge, SM Gadgeel, R Rosell, R Dziadziuszko, DW Kim, M Pérol, SI Ou, JS Ahn, AT Shaw, W Bordogna, V Smoljanović, M Hilton, T Ruf, J Noé, S Peters

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading